Heidelberg Pharma

As a drug development company, Heidelberg Pharma focuses on combining the targeting properties of antibodies with the potency of ultra-strong toxins in Antibody-Drug Conjugates (ADCs) to more effectively combat cancer. Our focus is on oncology, and our mission is to research and develop drugs for cancer patients, enabling them to receive targeted, customized treatments that are both highly effective and well-tolerated.